Condition: Leukemia · HSCT · Sponsor: Shahid Beheshti University
The goal of this clinical trial is to have a successful engraftment in after bone transplantation. Acute leukemia patient of both sexes aged 2 to 18 years, who are transplant candidates, participate in this study. Primary hypothesis is Patients receiving SMOF LIPID will have better grafts than patients receiving intralipid. Also, complications after surgery and malnutrition will be less in this group.
This description comes directly from the study's public registry record.
Zahra Vahdat Shariatpanahi, Professor · 0098-021-22357484 · nutritiondata@yahoo.com
Zahra Vahdat Shariatpanahi, Professor · 09122138186 · nutritiondata@yahoo.com
Always discuss trial participation with your own doctor first.
| Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran | Tehran, Iran | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06625372